149 related articles for article (PubMed ID: 17684143)
1. Modulation of human glutathione s-transferases by polyphenon e intervention.
Chow HH; Hakim IA; Vining DR; Crowell JA; Tome ME; Ranger-Moore J; Cordova CA; Mikhael DM; Briehl MM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1662-6. PubMed ID: 17684143
[TBL] [Abstract][Full Text] [Related]
2. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
4. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
5. Effects of repeated green tea catechin administration on human cytochrome P450 activity.
Chow HH; Hakim IA; Vining DR; Crowell JA; Cordova CA; Chew WM; Xu MJ; Hsu CH; Ranger-Moore J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2473-6. PubMed ID: 17164372
[TBL] [Abstract][Full Text] [Related]
6. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
Lovera J; Ramos A; Devier D; Garrison V; Kovner B; Reza T; Koop D; Rooney W; Foundas A; Bourdette D
J Neurol Sci; 2015 Nov; 358(1-2):46-52. PubMed ID: 26298797
[TBL] [Abstract][Full Text] [Related]
7. Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans.
Nijhoff WA; Grubben MJ; Nagengast FM; Jansen JB; Verhagen H; van Poppel G; Peters WH
Carcinogenesis; 1995 Sep; 16(9):2125-8. PubMed ID: 7554064
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E).
Fu H; He J; Mei F; Zhang Q; Hara Y; Ryota S; Lubet RA; Chen R; Chen DR; You M
Cancer Prev Res (Phila); 2009 Jun; 2(6):531-7. PubMed ID: 19470785
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
Henning SM; Niu Y; Liu Y; Lee NH; Hara Y; Thames GD; Minutti RR; Carpenter CL; Wang H; Heber D
J Nutr Biochem; 2005 Oct; 16(10):610-6. PubMed ID: 16081270
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
Nguyen MM; Ahmann FR; Nagle RB; Hsu CH; Tangrea JA; Parnes HL; Sokoloff MH; Gretzer MB; Chow HH
Cancer Prev Res (Phila); 2012 Feb; 5(2):290-8. PubMed ID: 22044694
[TBL] [Abstract][Full Text] [Related]
11. Specific induction of glutathione S-transferase GSTM2 subunit expression by epigallocatechin gallate in rat liver.
Chou FP; Chu YC; Hsu JD; Chiang HC; Wang CJ
Biochem Pharmacol; 2000 Sep; 60(5):643-50. PubMed ID: 10927022
[TBL] [Abstract][Full Text] [Related]
12. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis.
Dryden GW; Lam A; Beatty K; Qazzaz HH; McClain CJ
Inflamm Bowel Dis; 2013 Aug; 19(9):1904-12. PubMed ID: 23846486
[TBL] [Abstract][Full Text] [Related]
13. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
Lubet RA; Yang CS; Lee MJ; Hara Y; Kapetanovic IM; Crowell JA; Steele VE; Juliana MM; Grubbs CJ
Mol Cancer Ther; 2007 Jul; 6(7):2022-8. PubMed ID: 17620432
[TBL] [Abstract][Full Text] [Related]
15. Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis).
Fung ST; Ho CK; Choi SW; Chung WY; Benzie IF
Br J Nutr; 2013 Jun; 109(12):2199-207. PubMed ID: 23110850
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions.
Ahn WS; Yoo J; Huh SW; Kim CK; Lee JM; Namkoong SE; Bae SM; Lee IP
Eur J Cancer Prev; 2003 Oct; 12(5):383-90. PubMed ID: 14512803
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.
Szarka CE; Pfeiffer GR; Hum ST; Everley LC; Balshem AM; Moore DF; Litwin S; Goosenberg EB; Frucht H; Engstrom PF
Cancer Res; 1995 Jul; 55(13):2789-93. PubMed ID: 7796404
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway.
Wang D; Wang Y; Wan X; Yang CS; Zhang J
Toxicol Appl Pharmacol; 2015 Feb; 283(1):65-74. PubMed ID: 25585349
[TBL] [Abstract][Full Text] [Related]
19. Intervention with polyphenol-rich fruit juices results in an elevation of glutathione S-transferase P1 (hGSTP1) protein expression in human leucocytes of healthy volunteers.
Hofmann T; Liegibel U; Winterhalter P; Bub A; Rechkemmer G; Pool-Zobel BL
Mol Nutr Food Res; 2006 Dec; 50(12):1191-200. PubMed ID: 17131458
[TBL] [Abstract][Full Text] [Related]
20. A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
Gee JR; Saltzstein DR; Kim K; Kolesar J; Huang W; Havighurst TC; Wollmer BW; Stublaski J; Downs T; Mukhtar H; House MG; Parnes HL; Bailey HH
Cancer Prev Res (Phila); 2017 May; 10(5):298-307. PubMed ID: 28325826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
